title: Long-term survivorship analysis of hip arthroplasty with vitallium mold cup.
abstract: BACKGROUND
  Cup arthroplasty was used in the initial attempts to preserve the bone stock of the femoral head and neck for hip reconstruction. However, little conclusive data are available regarding its long-term survivorship.
  
  
  METHODS
  We present a long-term survivorship analysis (mean follow-up, 19.3 years; range, 5-36.6 years) after vitallium mold arthroplasty in 77 secondary osteoarthritic hips.
  
  
  RESULTS
  Kaplan-Meier survivorship analysis predicted a survival rate for vitallium mold arthroplasty of 81.6% (95% confidence interval [CI], 76.7-86.5) at 20 years and 59.1% (95% CI, 51.8-66.5) at 30 years, with conversion to total hip arthroplasty as the endpoint. The mean Merle d'Aubigné and Postel hip score showed a significant decrease in mobility from 4.12 (range, 3.18-5.86) 6 months after the operation to 3.19 (range, 1.7-4.6) at the last follow-up. No significant differences were observed for the pain score from 6 months after the operation (5.05; range, 4.2-5.9) to the last follow-up (4.46; range, 2.88-6.04)) or score for the ability to walk, from 6 months after the operation (2.5; range, 1.4-3.6) to the last follow-up (3.13; range, 1.59-4.67). Radiographically, the proximal and medial migration of the cup measured at the last follow-up was 10.4 +/- 5.4 mm (P < 0.01) and 0.2 +/- 2.1 mm (P > 0.05), respectively.
  
  
  CONCLUSIONS
  Our results indicate inferior long-term survivorship after vitallium mold compared with that after Charnley low-friction arthroplasty.
authors: Department of Orthopaedics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo, Kyoto 606-8507, Japan.
authors: Hai-Le
authors: HL
authors: Pan
authors: Haruhiko
authors: H
authors: Akiyama
authors: Keiichi
authors: K
authors: Kawanabe
authors: Koji
authors: K
authors: Goto
authors: Kazutaka
authors: K
authors: So
authors: Takashi
authors: T
authors: Nakamura
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D004867:Equipment Design / Q000009:adverse effects; D019544:Equipment Failure Analysis; D005260:Female; D006622:Hip Prosthesis; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D012086:Reoperation; D017741:Survivors; D014800:Vitallium; D055815:Young Adult
chemical_list: D014800:Vitallium